Comparison of camrelizumab, pembrolizumab, tislelizumab, and sintilimab as first-line treatment in patients with non-small cell lung cancer: a retrospective study
@article{JTD96416,
author = {Xiaoqi Yan and Yizong Wang and Fei Wu and Guoren Zhou and Jiannan Shen and Shaorong Yu},
title = {Comparison of camrelizumab, pembrolizumab, tislelizumab, and sintilimab as first-line treatment in patients with non-small cell lung cancer: a retrospective study},
journal = {Journal of Thoracic Disease},
volume = {17},
number = {2},
year = {2025},
keywords = {},
abstract = {},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/96416}
}